This marks an exciting milestone as Healthcare Alliance and AIVision officially signed a Strategic Partnership MOU, bringing together healthcare expertise... Read more
Category: Uncategorized
Transforming Every HCP Interaction Into A Meaningful Call
On September 15–16, 𝐇𝐂𝐗 𝐂𝐨𝐚𝐜𝐡𝐢𝐧𝐠, in collaboration with 𝐇𝐲𝐩𝐡𝐞𝐧𝐬 𝐏𝐡𝐚𝐫𝐦𝐚, delivered the 𝐁.𝐄.𝐒.𝐓 (𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐄𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞 𝐒𝐞𝐥𝐥𝐢𝐧𝐠 𝐓𝐨𝐨𝐥𝐬) training program an intensive sales excellence course... Read more
Infectious Disease & Oligonucleotide Milestone: Japan MHLW Grants World-First Approval for GSK’s Hibsago® (Bepirovirsen) as Pioneer Functional Cure for Chronic Hepatitis B
Key Development On August 25, 2026, Japan’s Ministry of Health, Labour and Welfare (MHLW) approved Hibsago® (bepirovirsen), an investigational antisense... Read more
Upper GI Immuno-Oncology Milestone: US FDA Approves BeOne Medicines’ TEVIMBRA® (Tislelizumab) Regimen Combined with ZIIHERA® (Zanidatamab) and Chemotherapy in First-Line HER2-Positive GEA, Delivering 26.4 Months Median Overall Survival
Key Development On August 26, 2026, global oncology biopharmaceutical company BeOne Medicines announced that the U.S. Food and Drug Administration... Read more
SALES COMPETENCY – From evaluation to action
If we were given the right to build a world-class sales team from scratch, an excellent ETC or OTC channel... Read more
GHME – INSMART – VPBANK: CONTINUING THE JOURNEY OF EMERGENCY READINESS
On August 22, 2026, another chapter of the Basic Pre-Hospital Emergency Care Training Program unfolded as GLOBAL HEALTH & MEDICAL... Read more
Precision Oncology & Companion Diagnostics: US FDA Approves Roche’s PATHWAY HER2 (4B5) and VENTANA HER2 Dual ISH Assays as First Companion Diagnostics for HER2-Positive Esophageal and Metastatic Gastroesophageal Adenocarcinoma (GEA) to Direct ZIIHERA® Therapy
Key Development The U.S. Food and Drug Administration (FDA) has granted expanded approval for two companion diagnostic (CDx) assays developed... Read more
DR. TALK | OFFICE ERGONOMICS – SMALL ADJUSTMENTS FOR LONG-TERM WELLBEING
On August 12, 2026, GLOBAL HEALTH & MEDICAL EDUCATION - GHME, in collaboration with Schneider Electric, successfully delivered a Dr.... Read more
Biopharmaceutical Services & Oncology M&A: McKesson Expands Clinical Research and Commercialization Platform with $2.25 Billion Acquisition of Precision Medicine Group
Key Development Healthcare services and biopharmaceutical solutions enterprise McKesson Corporation (NYSE: MCK) has entered into a definitive agreement to acquire... Read more









